Leadership

Executive Team

Deep rooted experience leveraged from healthcare operations to world-class technology solutions, our team is the heart and soul of what we do each and every day.

Prad Sekar

Chief Executive Officer & Co-Founder

Mr. Sekar has spent over 15 years in clinical practice management owning, operating and consulting with outpatient multi-disciplinary healthcare practices in Canada and the US. Mr. Sekar holds a BSc Hon from the University of the Ottawa and a MBA from Hult International Business School. Following a career in establishing and operating successful medical practices, Mr. Sekar began consulting with Canadian medical regulatory bodies and agencies to support their network of practitioners in the establishment and operation of medical clinics. Mr. Sekar is also a recognized professor with a registered program for Medical Office Assistants under the Ontario Ministry of Education.

Mohammad Bataineh

President

Mr. Bataineh brings more than 20 years of extensive primary care operations, healthcare M&A, integration and change management and legal experience.  An attorney by trade, Mohammad was recently a Partner with healthcare-focused legal firm Bataineh Palmeri focusing on the firm’s transactional work.  Previously, he worked at the US Department of Commerce – Commercial Law Development Program and sites on the boards of OneJax Inc., and American Faces.  Mr. Bataineh is also a frequent lecturer and guest speaker, including the diversity panel discussion hosted by Florida Coastal School of Law.

Kash Qureshi

Chief Corporate Officer & Co-Founder

As co-founder of Skylight Health Group, Mr. Qureshi brings more than 20 years of extensive operational and entrepreneurial experience in the sales, commercial financing, technology, and the last 10 years directly involved in healthcare, wellness and health technology. An ardent cost-efficiency executive, Mr. Qureshi has focused on technology infrastructure, operational proficiencies, overall profitability, as well as acquisitions in a series of organizations throughout the healthcare sector.

Andrew Elinesky

Chief Financial Officer

A well-tenured financial professional, Mr. Elinesky brings over 20 years of experience as a CFO and senior financial leader for publicly traded companies in both Canada and the US.  With a focus on M&A and consolidation experience, Andrew was SVP and CFO at McEwen Mining where he managed equity and debt financing of over $150M and a $35M asset acquisition and $40M company acquisition.  He also has held various senior leadership and treasury roles at Heinz UK, Diageo, and Worldcom UK.  Andrew graduated from Oxford Brookes University and is Treasurer for the Canadian Network for the Prevention of Elder Abuse.

Dr. Kit Brekhus, MD.

Chief Medical Officer

Dr. Brekhus brings over 25 years of primary care and family medicine experience as both a clinician and an owner-operator of a free-standing family practice and full-service urgent care center.  He also served as Medical Director of Outreach services for a large healthcare system and helped lead the growth and development of the Colorado Community Health Alliance.  Prior to joining Skylight, Dr. Brekhus served several years as the founding board member, physician director and chief medical executive for one of the largest clinically integrated networks in the Rocky Mountain region dedicated to advancing value-based care where he was responsible for overseeing a network of more than 5,000 providers and managing more than 250,000 lives in various value-based agreements.

Dan Thompson

Chief Communications Officer

Dan brings over 20 years of marketing experience with high-growth public and private technology companies. Dan built and led the marketing divisions for early-stage companies in retail, travel and payment technology. Dan graduated from Michigan State University with degrees in marketing and communications.

Stephanie Gluchacki

SVP, Compliance

With over a decade of experience in the US healthcare market, Ms. Gluchacki has led the multi-state management of multiple medical clinics and clinic brands in both the primary care and specialty medicine space.  She brings an acute focus to governance, regulations and financial management, having served as President of Clinical Operations for a major US clinic brand.

Board of Directors

Patrick McNamee
Chairman of the Board

Patrick brings substantial healthcare leadership having been EVP and COO of Express Scripts (NASDAQ:ESRX), where he led all major activities of the technology-driven pharmacy benefit management company.  With a focus on organic and acquisitive growth, McNamee was instrumental in bringing the company from $3B in revenue to over $120B.  He also is the former President and CEO of Health Insurance Innovations where he led a significant and fast turnaround increasing the share price from $4 to $58 in less than 2 years.

Norton Singhavon

Norton is the Founder, Chairman & CEO of GTEC Holdings and has extensive experience in capital investments, acquisitions, consolidations, and start-ups in Canada’s private and public cannabis sector. He has deployed over $100 million into the North American cannabis industry and has been involved in numerous public M& A cannabis transactions and was an early stage advisor to major Licensed Producers, including Cronos Group.

Grace Mellis

Grace brings nearly three decades of strategy, finance, and capital markets experience with executive roles at JP Morgan Chase including as Head of International Strategy and as Investor Services CFO for EMEA.  Ms. Mellis is also the former Chief Financial Officer at Greendot Corporation, a US$3.1B market cap NYSE-listed company.  She is also a mentor and investor with Techstars, a global start-up incubation platform.

Peter Cummins

Peter has spent over two decades with Johnson & Johnson, including executive leadership roles overseeing research and development, product development, external innovation, regulatory affairs and hospital pharmacy across Canada, US, Europe and other regions. He has also served in Regulatory and Scientific Affairs at Procter & Gamble and was the Director of Pharmacy at Cambridge Memorial Hospital.

Tom Brogan

Tom Brogan brings 40 years experience in aggregating anonymized healthcare data to create insights to support traditional pharmaceutical companies and for use in health economic studies.  His innovations include a long list of applications that merge Real World Evidence with traditional healthcare protocols. Mr. Brogan is currently the CEO and Chairman at Vestrum Health, an electronic healthcare record data company which delivers information systems to pharmaceutical manufacturers, physician practices and other healthcare stakeholders. Prior to Vestrum Health, he was the founder of Brogan Consulting, which was acquired by IMS in 2010, now IQVIA, one of the world’s largest Contract Research Organizations (CROs), following which Mr. Brogan continued on with the company as Vice President of Global Oncology at IMS Health.

Prad Sekar

Mr. Sekar has spent over 15 years in clinical practice management owning, operating and consulting with outpatient multi-disciplinary healthcare practices in Canada and the US. Mr. Sekar holds a BSc Hon from the University of the Ottawa and a MBA from Hult International Business School. Following a career in establishing and operating successful medical practices, Mr. Sekar began consulting with Canadian medical regulatory bodies and agencies to support their network of practitioners in the establishment and operation of medical clinics. Mr. Sekar is also a recognized professor with a registered program for Medical Office Assistants under the Ontario Ministry of Education.

Kash Qureshi

As co-founder of Skylight Health Group, Mr. Qureshi brings more than 20 years of extensive operational and entrepreneurial experience in the sales, commercial financing, technology, and the last 10 years directly involved in healthcare, wellness and health technology. An ardent cost-efficiency executive, Mr. Qureshi has focused on technology infrastructure, operational proficiencies, overall profitability, as well as acquisitions in a series of organizations throughout the healthcare sector.